James Taylor

The London arm of US-based VC group Accel Partners has bucked the dismal fundraising trend for European venture by racing to its target, thanks to strong support from US investors.

In the 10 years since the launch of Bridges Ventures, the UK group has witnessed a sea change in the way LPs think about social investment

Pye gets caught napping on value creation

Lessons in leadership from Heinz CEO William Johnson

Why David Rubenstein thinks politicians are like giant pandas

Tony James, and the evils of 'clarity equity'

The UK mid-market firm has sold Rosemont Pharmaceuticals to a US trade buyer for £180m – having more than doubled EBITDA during its period of ownership.

The UK mid-market firm has sold Rosemont Pharmaceuticals to a US trade buyer for £180m – having more than doubled EBITDA during its period of ownership.

Pye outlines his expertise in non-exec selection

Pye gets some novel words of encouragement from Big Shop's managing partner